# Carmat

> Artificial heart transplant alternative

Business model and tags: B2B, Publicly traded, Manufacturing, Healthtech, Hardware, Sales-led purchase, Pharma & life sciences, Medical devices, Multi-site, Has production sites, Has in-house R&D, Has a works council

## About Carmat

Designs, manufactures, and markets the Aeson artificial heart, a physiological and self-regulated device for end-stage biventricular heart failure patients awaiting transplant.

## Key facts

- **Industry**: Medical Equipment Manufacturing
- **Company size**: 251–1,000 employees
- **Headquarters**: Vélizy-Villacoublay, Île-de-France, France
- **Founded**: 2008
- **Revenue**: €7.3M (FY2024, publicly reported)
- **SIREN**: [504937905](https://annuaire-entreprises.data.gouv.fr/entreprise/504937905)
- **Website**: [carmatsa.com](https://www.carmatsa.com/)
- **LinkedIn**: [linkedin.com/company/carmat](https://www.linkedin.com/company/carmat)

## Carmat at a glance

Carmat is a B2B company in the Medical Equipment Manufacturing industry, headquartered in Vélizy-Villacoublay, Île-de-France, France.

Carmat was founded in 2008.

Carmat has 251–1,000 employees.

Carmat's revenue is €7.3M (FY2024, publicly reported).

Carmat's SIREN number is 504937905.

## Frequently asked questions about Carmat

### What is Carmat's revenue?

Carmat's revenue is €7.3M (FY2024, publicly reported).

### How many employees does Carmat have?

Carmat has 251–1,000 employees.

### Where is Carmat headquartered?

Carmat is headquartered in Vélizy-Villacoublay, Île-de-France, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/carmat
